BGLC
BioNexus Gene Lab CorpCompany with tickers: BGLC
CIK
1737523
CUSIP
090628306
Shares Outstanding
2,417,314
13F Activity (30d)
2 filings
2 filers
Price
$2.19
Market Cap
$5.28M
P/E Ratio
-24.28
EPS (Diluted)
$-0.09
52W High
$15.60
52W Low
$1.92
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | $22,842 | USD | 2026-03-31 | 10-Q | 2026-05-15 |
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | $23,632 | USD | 2026-03-31 | 10-Q | 2026-05-15 |
| Gross Profit | $-790 | USD | 2026-03-31 | 10-Q | 2026-05-15 |
| Operating Expenses | $597,386 | USD | 2026-03-31 | 10-Q | 2026-05-15 |
| Research & Development | $14,487 | USD | 2026-03-31 | 10-Q | 2026-05-15 |
| Operating Income | $-540,490 | USD | 2026-03-31 | 10-Q | 2026-05-15 |
| Net Income | $-543,575 | USD | 2026-03-31 | 10-Q | 2026-05-15 |
| EPS (Basic) | — | ||||
| EPS (Diluted) | $-0.23 | USD/shares | 2026-03-31 | 10-Q | 2026-05-15 |